Brazil health regulator allows resumption of China Covid vaccine trials
Testing was suspended after the death of a participant, but officials say it had no relation to the trials
Brazil’s health regulator has allowed resumption of late-stage clinical trials for China’s Sinovac Covid-19 vaccine, which had been suspended due to a study subject’s death that was registered in Sao Paulo as a suicide.
The Brazilian medical institute, Butantan, said in a statement it would restart trials later on Wednesday.
Leave a Reply